Pharmacogenomics of the cystic fibrosis transmembrane conductance regulator (CFTR) and the cystic fibrosis drug CPX using genome microarray analysis

Molecular Medicine

Volumn 5, Issue 11, 1999, Pages 753-767

  Srivastava, M ^a   Eidelman, O ^a   Pollard, H B ^a  

^a Uniformed Services University of the Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE CHANNEL; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; CYSTIC FIBROSIS; DNA MICROARRAY; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIPID BILAYER; NUCLEOTIDE SEQUENCE; PHARMACOGENOMICS; PRIORITY JOURNAL; TARGET CELL;

EID: 0033276659     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03402099     Document Type: Article

References (56)

1. Pharmacogenomics - It's not just pharmacogenetics
2. Pharmacogenomics: A new approach to individual therapy of hypertension?
3. Genomic profiling of drug sensitivities via induced haploinsufficiency
4. Cystic fibrosis
5. Cystic fibrosis molecular biology and therapeutic implications
6. Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer
7. In vitro pharmacologic restoration of CFTR-mediated chloride transport in sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR
8. Role of CPX in promoting trafficking and chloride channel activity of wildtype and mutant CFTR
9. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA
10. Identification of the cystic fibrosis gene: Chromosome walking and jumping
11. Identification of the cystic fibrosis gene: Genetic analysis
12. Mutations and sequence variations detected in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: A report from the cystic fibrosis genetic analysis consortium
13. The spectrum of cystic fibrosis mutations
14. Pharmacology of CFTR chloride channel activity
15. A1-adenosine antagonists activate chloride efflux from cystic fibrosis cells
16. G-proteins inhibit cAMP-activated chloride channels in normal and CF epithelia
17. A1-receptor antagonist 8 cyclopentyl-1,3-dipropyl-xanthine (CPX) selectively activates chloride efflux from human epithelial and mouse fibroblast cell lines expressing the CFTR(ΔF508) mutation, but not the wild type CFTR
18. Stimulation of alkylxanthines of chloride efflux from CFPAC-1 cells does not involve A1-adenosine receptors
19. CPX, a selective A1 adenosine receptor antagonist, regulates intracellular pH in cystic fibrosis cells
20. ΔF508-CFTR channels: Kinetics, activation by forskolin, and potentiation by xanthines
21. Direct activation of cystic fibrosis transmembrane conductance regulator by 8-cyclopentyl-1,3-dipropylxanthine and 1,3-diallyl-8-cyclohexylxanthine
22. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis
23. CPX (1,3-dipropyl-8-cyclopentyl xanthine) and other alkyl-xanthines differentially bind to the wild type and ΔF508 mutant first nucleotide binding fold (NBF-1) domains of the cystic fibrosis transmembrane conductance regulator (CFTR)
24. CFTR as a cAMP-dependent regulator of sodium channels
25. Regulation of epithelial sodium channels by the cystic fibrosis transmembrane conductance regulator
26. CFTR is a conductance regulator as well as a chloride channel
27. Adenosine A3 receptors: Novel ligands and paradoxical effects
28. Two cystic fibrosis transmembrane conductance regulator mutations have different effects on both pulmonary phenotype and regulation of outwardly rectified chloride currents
29. The risk of cancer among patients with cystic fibrosis
30. A cohort study of cystic fibrosis and malignancy
31. Colonic carcinoma in two adult cystic fibrosis patients
32. The epidemiology of cancer of the small bowel
33. Association of pancreatic adenocarcinoma, mild lung disease, and delta F508 mutation in a cystic fibrosis patient
34. Breast abnormalities in patients with cystic fibrosis: Previously unrecognised changes
35. CFTR deltaF508 carrier status, risk of breast cancer before the age of 40 and histological grading in a population-based case-control study
36. The cystic fibrosis delta F508 mutation and cancer
37. A pancreatic cancer-specific expression profile
38. Discovery and analysis of inflammatory disease-related genes using cDNA microarrays
39. Microdissection, microchip arrays, and molecular analysis of tumor cells (primary and metastases)
40. Novel gene transcripts preferentially expressed in human muscles revealed by quantitative hybridization of a high density cDNA array
41. Parallel human genome analysis: Microarray-based expression monitoring of 1000 genes
42. Detection of differentially expressed genes in primary tumor tissues using representational differences analysis coupled to microarray hybridization
43. High density synthetic oligonucleotide arrays
44. Gene chips and arrays revealed: A primer on the power and their uses
45. Probing lymphocyte biology by genome-scale gene expression analysis
46. Use of a cDNA microarray to analyse gene expression patterns in human cancer
47. Stimulation of B and T cells activates expression of transcription and differentiation factors
48. Profiling of differentially expressed genes in human primary cervical cancer by complementary DNA expression array
49. Slow conversions among subconductance states of cystic fibrosis transmembrane conductance regulator chloride channel
50. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
51. Control of CFTR channel gating by phosphorylation and nucleotide hydrolysis
52. 2 receptors stimulate mitogen-activated protein kinase in human embryonic kidney-293 cells
53. Mitogenic action of adenosine on osteoblast-like cells, MC3T3-E1
54. Adenosine stimulation of DNA synthesis in mammary epithelial cells
55. Adenosine modulates cell proliferation in human colonic adenocarcinoma. I. Possible involvement of A1 receptor subtypes in HT29 cells
56. Gene expression informatics - It's all in your mine